NewsRoom Articles - Page 859 of 1390

TuesdayMar 19, 2019 11:30 am

Oragenics Inc. (NYSE American: OGEN) Attends 31st Annual ROTH Conference

Oragenics (NYSE American: OGEN) is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics has established two exclusive worldwide channel collaborations with Intrexon Corporation and its subsidiaries. The collaborations allow Oragenics to accelerate the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus. For more information, visit the company's website at www.oragenics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

TuesdayMar 19, 2019 11:30 am

OptimizeRx Corp. (NASDAQ: OPRX) Attends 31st Annual ROTH Conference

OptimizeRx (NASDAQ: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest point-of-prescribe promotional platform for the pharmaceutical industry, OptimizeRx provides a direct channel for pharma companies to communicate with healthcare providers right within their workflow. The cloud-based solution supports patient adherence to medications with real-time access to financial assistance, prior authorization, education and critical clinical information. The company’s mobile messaging platform also supports direct, real-time communication to patients for improved medication adherence, affordability, and healthcare outcomes. For more information, visit the company's website…

TuesdayMar 19, 2019 11:30 am

OpGen Inc. (NASDAQ: OPGN) Attends 31st Annual ROTH Conference

OpGen (NASDAQ: OPGN) is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital, and network-wide infection treatment and prevention. The Acuitas Lighthouse Software (RUO) is the first cloud-based software to predict antibiotic resistance, track antimicrobial resistance, and determine bacterial strain relatedness in healthcare settings using bacterial genetic data. The Acuitas AMR Gene Panel (RUO) is the most comprehensive, rapid PCR test for detecting five pathogens and 47 resistance genes which cover nine antibiotic classes. OpGen’s solutions will provide the power to prescribe empiric therapy with precision. For more information, visit the company's website at…

TuesdayMar 19, 2019 11:30 am

Clearfield Inc. (NASDAQ: CLFD) Attends 31st Annual ROTH Conference

Clearfield (NASDAQ: CLFD) designs, manufactures and distributes fiber optic management, protection and delivery products for communications networks. The company’s “fiber to anywhere” platform serves the unique requirements of leading incumbent local exchange carriers (traditional carriers), competitive local exchange carriers (alternative carriers), and MSO/cable TV companies, while also catering to the broadband needs of the utility/municipality, enterprise, data center and military markets. Headquartered in Minneapolis, Minnesota, Clearfield deploys more than a million fiber ports each year. For more information, visit the company's website at www.SeeClearfield.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…

TuesdayMar 19, 2019 11:30 am

Clarus Corp. (NASDAQ: CLAR) Attends 31st Annual ROTH Conference

Clarus (NASDAQ: CLAR) is focused on the outdoor and consumer industries, where it seeks opportunities to acquire and grow businesses that can generate attractive shareholder returns. The company has substantial net operating tax loss carryforwards which it is seeking to redeploy to maximize shareholder value. Clarus’ primary business is as a leading developer, manufacturer and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, and sport categories. The company’s products are principally sold under the Black Diamond®, Sierra® and PIEPS® brand names through specialty and online retailers, distributors and original equipment manufacturers throughout the U.S. and…

TuesdayMar 19, 2019 11:30 am

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Attends 31st Annual ROTH Conference

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. Citius seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For…

TuesdayMar 19, 2019 11:30 am

CohBar Inc. (NASDAQ: CWBR) Attends 31st Annual ROTH Conference

CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company focused on the research and development of mitochondria-based therapeutics (MBTs), an emerging class of drugs for the treatment of age-related diseases. MBTs originate from the discovery by CohBar’s founders of a novel group of peptides within the mitochondrial genome which regulate metabolism and cell death, and whose biological activity declines with age. CohBar’s efforts focus on the development of these mitochondrial-derived peptides (MDPs) into clinically relevant MBTs that offer the potential to address a broad range of age-related diseases with underlying metabolic dysfunction. For more information, visit the company's website at www.cohbar.com.…

TuesdayMar 19, 2019 11:30 am

Coeur Mining Inc. (NYSE: CDE) Attends 31st Annual ROTH Conference

Coeur Mining (NYSE: CDE) is a well-diversified growing precious metals producer with five mines in North America. Coeur produces from its wholly owned operations: the Palmarejo silver-gold complex in Mexico, the Silvertip silver-zinc-lead mine in British Columbia, the Rochester silver-gold mine in Nevada, the Wharf gold mine in South Dakota, and the Kensington gold mine in Alaska. In addition, the company has interests in several precious metals exploration projects throughout North America. For more information, visit the company's website at www.coeur.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network…

TuesdayMar 19, 2019 11:30 am

Codexis Inc. (NASDAQ: CDXS) Attends 31st Annual ROTH Conference

Codexis (NASDAQ: CDXS) is a protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, visit the company's website at www.codexis.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire…

TuesdayMar 19, 2019 11:00 am

ObsEva SA (NASDAQ: OBSV) Attends 31st Annual ROTH Conference

ObsEva SA (NASDAQ: OBSV) is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving IVF outcomes. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, visit the company's website at www.ObsEva.com.…